Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
121.61
+1.19 (0.99%)
At close: Nov 8, 2024, 4:00 PM
120.00
-1.61 (-1.32%)
After-hours: Nov 8, 2024, 7:36 PM EST
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of $11.62 billion as of November 8, 2024. Its market cap has increased by 16.12% in one year.
Market Cap
11.62B
Enterprise Value
11.83B
1-Year Change
16.12%
Ranking
Category
Stock Price
$121.61
Market Cap Chart
Since December 1, 1998, Sarepta Therapeutics's market cap has increased from $58.40M to $11.62B, an increase of 19,790.66%. That is a compound annual growth rate of 22.62%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 7, 2024 | 11.50B | 27.51% |
Dec 29, 2023 | 9.02B | -20.70% |
Dec 30, 2022 | 11.37B | 45.06% |
Dec 31, 2021 | 7.84B | -41.72% |
Dec 31, 2020 | 13.45B | 39.87% |
Dec 31, 2019 | 9.62B | 31.90% |
Dec 31, 2018 | 7.29B | 102.79% |
Dec 29, 2017 | 3.60B | 140.16% |
Dec 30, 2016 | 1.50B | -14.27% |
Dec 31, 2015 | 1.75B | 192.17% |
Dec 31, 2014 | 597.80M | -21.92% |
Dec 31, 2013 | 765.60M | 16.58% |
Dec 31, 2012 | 656.70M | 549.55% |
Dec 30, 2011 | 101.10M | -57.54% |
Dec 31, 2010 | 238.10M | 47.70% |
Dec 31, 2009 | 161.20M | 244.44% |
Dec 31, 2008 | 46.80M | -38.26% |
Dec 31, 2007 | 75.80M | -54.99% |
Dec 29, 2006 | 168.40M | 10.50% |
Dec 30, 2005 | 152.40M | 79.51% |
Dec 31, 2004 | 84.90M | -33.15% |
Dec 31, 2003 | 127.00M | -3.93% |
Dec 31, 2002 | 132.20M | -47.73% |
Dec 31, 2001 | 252.90M | 148.18% |
Dec 29, 2000 | 101.90M | 40.36% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Dr. Reddy's Laboratories | 12.87B |
Solventum | 12.80B |
Neurocrine Biosciences | 12.69B |
BioMarin Pharmaceutical | 12.61B |
Fresenius Medical Care AG | 12.30B |
DaVita | 12.06B |
Bio-Techne | 12.05B |
AptarGroup | 11.52B |